Anti-TNF-alpha therapy for acute rejection in intestinal transplantation

Transplantation Proceedings

Volumn 37, Issue 3, 2005, Pages 1635-1636

  Pascher, A ^a   Klupp, J ^a   Langrehr, J M ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; DACLIZUMAB; INFLIXIMAB; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ANTIBODY;

ACUTE GRAFT REJECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INFUSION; DRUG RESPONSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; REMISSION; SALVAGE THERAPY; SYMPTOM;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; GASTROINTESTINAL AGENTS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; MUROMONAB-CD3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19044393031     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.09.023     Document Type: Conference Paper

References (3)

1. A. Pascher, C. Radke, A. Dignass Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation Transplantation 76 2003 615
2. G. Kobbe, P. Schneider, U. Rohr Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse anti TNFalpha antibody Bone Marrow Transplantation 28 2001 47
3. A. Lugering, M. Schmidt, N. Lugering Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway Gastroenterology 121 2001 1145